List of Tables
Table 1. Global Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of AAV
Table 3. Key Players of Lentivirus
Table 4. Key Players of Adenovirus
Table 5. Key Players of HSV
Table 6. Key Players of Others
Table 7. Global Viral Vector Manufacturing for Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Viral Vector Manufacturing for Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Viral Vector Manufacturing for Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 10. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region (2021–2026)
Table 11. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region (2027–2032)
Table 13. Viral Vector Manufacturing for Gene Therapy Market Trends
Table 14. Viral Vector Manufacturing for Gene Therapy Market Drivers
Table 15. Viral Vector Manufacturing for Gene Therapy Market Challenges
Table 16. Viral Vector Manufacturing for Gene Therapy Market Restraints
Table 17. Global Viral Vector Manufacturing for Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 18. Global Viral Vector Manufacturing for Gene Therapy Market Share by Players (2021–2026)
Table 19. Global Top Viral Vector Manufacturing for Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Viral Vector Manufacturing for Gene Therapy Revenue, 2025
Table 20. Ranking of Global Top Viral Vector Manufacturing for Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing for Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Headquarters and Area Served
Table 23. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Products and Applications
Table 24. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Viral Vector Manufacturing for Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 27. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Type (2021–2026)
Table 28. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Type (2027–2032)
Table 30. Global Viral Vector Manufacturing for Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 31. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Application (2021–2026)
Table 32. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Application (2027–2032)
Table 34. North America Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. North America Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific Viral Vector Manufacturing for Gene Therapy Product
Table 52. Thermo Fisher Scientific Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 53. Thermo Fisher Scientific Recent Development
Table 54. Lonza Company Details
Table 55. Lonza Business Overview
Table 56. Lonza Viral Vector Manufacturing for Gene Therapy Product
Table 57. Lonza Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 58. Lonza Recent Development
Table 59. Catalent Company Details
Table 60. Catalent Business Overview
Table 61. Catalent Viral Vector Manufacturing for Gene Therapy Product
Table 62. Catalent Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 63. Catalent Recent Development
Table 64. Charles River Company Details
Table 65. Charles River Business Overview
Table 66. Charles River Viral Vector Manufacturing for Gene Therapy Product
Table 67. Charles River Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 68. Charles River Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Viral Vector Manufacturing for Gene Therapy Product
Table 72. Merck Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 73. Merck Recent Development
Table 74. SK pharmteco Company Details
Table 75. SK pharmteco Business Overview
Table 76. SK pharmteco Viral Vector Manufacturing for Gene Therapy Product
Table 77. SK pharmteco Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 78. SK pharmteco Recent Development
Table 79. Oxford Biomedica Company Details
Table 80. Oxford Biomedica Business Overview
Table 81. Oxford Biomedica Viral Vector Manufacturing for Gene Therapy Product
Table 82. Oxford Biomedica Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 83. Oxford Biomedica Recent Development
Table 84. AGC Biologics（MolMed） Company Details
Table 85. AGC Biologics（MolMed） Business Overview
Table 86. AGC Biologics（MolMed） Viral Vector Manufacturing for Gene Therapy Product
Table 87. AGC Biologics（MolMed） Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 88. AGC Biologics（MolMed） Recent Development
Table 89. Gene Universal Company Details
Table 90. Gene Universal Business Overview
Table 91. Gene Universal Viral Vector Manufacturing for Gene Therapy Product
Table 92. Gene Universal Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 93. Gene Universal Recent Development
Table 94. Polyplus (Sartorius) Company Details
Table 95. Polyplus (Sartorius) Business Overview
Table 96. Polyplus (Sartorius) Viral Vector Manufacturing for Gene Therapy Product
Table 97. Polyplus (Sartorius) Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 98. Polyplus (Sartorius) Recent Development
Table 99. CCRM Company Details
Table 100. CCRM Business Overview
Table 101. CCRM Viral Vector Manufacturing for Gene Therapy Product
Table 102. CCRM Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 103. CCRM Recent Development
Table 104. FUJIFILM Diosynth Biotechnologies Company Details
Table 105. FUJIFILM Diosynth Biotechnologies Business Overview
Table 106. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing for Gene Therapy Product
Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 108. FUJIFILM Diosynth Biotechnologies Recent Development
Table 109. Biovian Company Details
Table 110. Biovian Business Overview
Table 111. Biovian Viral Vector Manufacturing for Gene Therapy Product
Table 112. Biovian Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 113. Biovian Recent Development
Table 114. Miltenyi Bioindustry Company Details
Table 115. Miltenyi Bioindustry Business Overview
Table 116. Miltenyi Bioindustry Viral Vector Manufacturing for Gene Therapy Product
Table 117. Miltenyi Bioindustry Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 118. Miltenyi Bioindustry Recent Development
Table 119. Aldevron Company Details
Table 120. Aldevron Business Overview
Table 121. Aldevron Viral Vector Manufacturing for Gene Therapy Product
Table 122. Aldevron Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 123. Aldevron Recent Development
Table 124. Takara Bio Company Details
Table 125. Takara Bio Business Overview
Table 126. Takara Bio Viral Vector Manufacturing for Gene Therapy Product
Table 127. Takara Bio Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 128. Takara Bio Recent Development
Table 129. Yposkesi Company Details
Table 130. Yposkesi Business Overview
Table 131. Yposkesi Viral Vector Manufacturing for Gene Therapy Product
Table 132. Yposkesi Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 133. Yposkesi Recent Development
Table 134. Genezen Company Details
Table 135. Genezen Business Overview
Table 136. Genezen Viral Vector Manufacturing for Gene Therapy Product
Table 137. Genezen Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 138. Genezen Recent Development
Table 139. Exthera Company Details
Table 140. Exthera Business Overview
Table 141. Exthera Viral Vector Manufacturing for Gene Therapy Product
Table 142. Exthera Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 143. Exthera Recent Development
Table 144. Flash Therapeutics Company Details
Table 145. Flash Therapeutics Business Overview
Table 146. Flash Therapeutics Viral Vector Manufacturing for Gene Therapy Product
Table 147. Flash Therapeutics Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 148. Flash Therapeutics Recent Development
Table 149. VIVEBiotech Company Details
Table 150. VIVEBiotech Business Overview
Table 151. VIVEBiotech Viral Vector Manufacturing for Gene Therapy Product
Table 152. VIVEBiotech Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 153. VIVEBiotech Recent Development
Table 154. FinVector Company Details
Table 155. FinVector Business Overview
Table 156. FinVector Viral Vector Manufacturing for Gene Therapy Product
Table 157. FinVector Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 158. FinVector Recent Development
Table 159. uBriGene Company Details
Table 160. uBriGene Business Overview
Table 161. uBriGene Viral Vector Manufacturing for Gene Therapy Product
Table 162. uBriGene Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 163. uBriGene Recent Development
Table 164. Eurogentec Company Details
Table 165. Eurogentec Business Overview
Table 166. Eurogentec Viral Vector Manufacturing for Gene Therapy Product
Table 167. Eurogentec Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 168. Eurogentec Recent Development
Table 169. VGXI Company Details
Table 170. VGXI Business Overview
Table 171. VGXI Viral Vector Manufacturing for Gene Therapy Product
Table 172. VGXI Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 173. VGXI Recent Development
Table 174. GenScript ProBio Company Details
Table 175. GenScript ProBio Business Overview
Table 176. GenScript ProBio Viral Vector Manufacturing for Gene Therapy Product
Table 177. GenScript ProBio Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 178. GenScript ProBio Recent Development
Table 179. EurekaBio Company Details
Table 180. EurekaBio Business Overview
Table 181. EurekaBio Viral Vector Manufacturing for Gene Therapy Product
Table 182. EurekaBio Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 183. EurekaBio Recent Development
Table 184. Obio Technology Company Details
Table 185. Obio Technology Business Overview
Table 186. Obio Technology Viral Vector Manufacturing for Gene Therapy Product
Table 187. Obio Technology Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 188. Obio Technology Recent Development
Table 189. GeneSail Biotech Company Details
Table 190. GeneSail Biotech Business Overview
Table 191. GeneSail Biotech Viral Vector Manufacturing for Gene Therapy Product
Table 192. GeneSail Biotech Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 193. GeneSail Biotech Recent Development
Table 194. VectorBuilder Company Details
Table 195. VectorBuilder Business Overview
Table 196. VectorBuilder Viral Vector Manufacturing for Gene Therapy Product
Table 197. VectorBuilder Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 198. VectorBuilder Recent Development
Table 199. WuXi ATU Company Details
Table 200. WuXi ATU Business Overview
Table 201. WuXi ATU Viral Vector Manufacturing for Gene Therapy Product
Table 202. WuXi ATU Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 203. WuXi ATU Recent Development
Table 204. Ubrigene Company Details
Table 205. Ubrigene Business Overview
Table 206. Ubrigene Viral Vector Manufacturing for Gene Therapy Product
Table 207. Ubrigene Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 208. Ubrigene Recent Development
Table 209. Porton Biologics Company Details
Table 210. Porton Biologics Business Overview
Table 211. Porton Biologics Viral Vector Manufacturing for Gene Therapy Product
Table 212. Porton Biologics Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 213. Porton Biologics Recent Development
Table 214. Pharmaron Company Details
Table 215. Pharmaron Business Overview
Table 216. Pharmaron Viral Vector Manufacturing for Gene Therapy Product
Table 217. Pharmaron Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 218. Pharmaron Recent Development
Table 219. PackGene Biotechnology Company Details
Table 220. PackGene Biotechnology Business Overview
Table 221. PackGene Biotechnology Viral Vector Manufacturing for Gene Therapy Product
Table 222. PackGene Biotechnology Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 223. PackGene Biotechnology Recent Development
Table 224. Hillgene Company Details
Table 225. Hillgene Business Overview
Table 226. Hillgene Viral Vector Manufacturing for Gene Therapy Product
Table 227. Hillgene Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 228. Hillgene Recent Development
Table 229. Asymchem Company Details
Table 230. Asymchem Business Overview
Table 231. Asymchem Viral Vector Manufacturing for Gene Therapy Product
Table 232. Asymchem Revenue in Viral Vector Manufacturing for Gene Therapy Business (US$ Million), 2021–2026
Table 233. Asymchem Recent Development
Table 234. Research Programs/Design for This Report
Table 235. Key Data Information from Secondary Sources
Table 236. Key Data Information from Primary Sources
Table 237. Authors List of This Report
List of Figures
Figure 1. Viral Vector Manufacturing for Gene Therapy Picture
Figure 2. Global Viral Vector Manufacturing for Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Viral Vector Manufacturing for Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. AAV Features
Figure 5. Lentivirus Features
Figure 6. Adenovirus Features
Figure 7. HSV Features
Figure 8. Others Features
Figure 9. Global Viral Vector Manufacturing for Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Viral Vector Manufacturing for Gene Therapy Market Share by Application: 2025 vs 2032
Figure 11. Vaccine Development Case Studies
Figure 12. Gene Therapy Case Studies
Figure 13. Academic Scientific Research Institution Case Studies
Figure 14. Others Case Studies
Figure 15. Viral Vector Manufacturing for Gene Therapy Report Years Considered
Figure 16. Global Viral Vector Manufacturing for Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 17. Global Viral Vector Manufacturing for Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region: 2025 vs 2032
Figure 19. Global Viral Vector Manufacturing for Gene Therapy Market Share by Players in 2025
Figure 20. Global Viral Vector Manufacturing for Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing for Gene Therapy Revenue in 2025
Figure 22. North America Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. North America Viral Vector Manufacturing for Gene Therapy Market Share by Country (2021–2032)
Figure 24. United States Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Canada Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Viral Vector Manufacturing for Gene Therapy Market Share by Country (2021–2032)
Figure 28. Germany Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. France Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. U.K. Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Italy Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Russia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Ireland Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Share by Region (2021–2032)
Figure 36. China Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Japan Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. South Korea Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Southeast Asia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. India Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Australia & New Zealand Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Viral Vector Manufacturing for Gene Therapy Market Share by Country (2021–2032)
Figure 44. Mexico Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Brazil Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Share by Country (2021–2032)
Figure 48. Israel Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Saudi Arabia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. UAE Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 52. Lonza Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 53. Catalent Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 54. Charles River Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 55. Merck Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 56. SK pharmteco Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 57. Oxford Biomedica Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 58. AGC Biologics（MolMed） Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 59. Gene Universal Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 60. Polyplus (Sartorius) Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 61. CCRM Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 63. Biovian Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 64. Miltenyi Bioindustry Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 65. Aldevron Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 66. Takara Bio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 67. Yposkesi Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 68. Genezen Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 69. Exthera Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 70. Flash Therapeutics Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 71. VIVEBiotech Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 72. FinVector Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 73. uBriGene Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 74. Eurogentec Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 75. VGXI Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 76. GenScript ProBio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 77. EurekaBio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 78. Obio Technology Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 79. GeneSail Biotech Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 80. VectorBuilder Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 81. WuXi ATU Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 82. Ubrigene Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 83. Porton Biologics Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 84. Pharmaron Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 85. PackGene Biotechnology Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 86. Hillgene Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 87. Asymchem Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2021–2026)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
